jueves, 7 de agosto de 2025

FDA grants accelerated approval to dordaviprone for diffuse midline glioma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario